Dr. Mehra Golshan is the incumbent Dr. Abdul Mohsen and Sultana Al-Tuwaijri Distinguished Chair in Surgical Oncology at the Brigham and Women’s Hospital. He is also the Director of the Breast Surgical Oncology Fellowship at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital/Massachusetts General Hospital and an Associate Professor of Surgery at Harvard Medical School. He chairs the Dana Farber/Brigham and Women’s Cancer Center: Committee for the American College of Surgeon’s Commission on Cancer and serves as the Cancer Liaison Physician as well.
Dr. Golshan received his medical degree from Case Western Reserve University School of Medicine. He completed a residency in general surgery at Rush-Presbyterian-Saint Luke's Medical Center and a breast surgical oncology fellowship at Northwestern Memorial Hospital. He is board certified in surgery. He runs a busy clinical practice focused exclusively on breast surgical oncology, a robust clinical trials group and completed his MBA at MIT Sloan School of Management in May of 2019.
The author of over 115 peer-reviewed publications and recipient of funding from the Breast Cancer Research Foundation and the National Institutes of Health, Dr. Golshan focuses his clinical research on minimizing the extent of surgery required for women with breast cancer through the use of neoadjuvant therapies and novel intra-operative imaging and margin analysis techniques. He is studying the use of intra-operative diagnostic biomarkers and tools in BWH’s Advanced Multimodality Image Guided Operative Suite to determine if they can identify and remove residual tumor with the aim of improving patient outcomes and reducing re-excision rates. Dr. Golshan is also a leading researcher on tailoring the extent of surgery and therapy for women with early-stage breast cancer. Dr. Golshan has been consistently named one of America’s Top Doctors by Castle Connolly and named a top surgeon in Boston Magazine.